Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004936 |
---|---|
Receipt number | R000005877 |
Scientific Title | Palonosetron+Aprepitant+Dexamethasone for moderately emetic chemotherapy induced nausea and voimiting-Phase II study- |
Date of disclosure of the study information | 2011/01/24 |
Last modified on | 2018/06/14 10:41:23 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/01/24 16:10:26 | ||
2 | Update | 2012/06/08 09:14:54 | Gender Target sample size |
|
3 | Update | 2012/06/08 09:15:40 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2013/04/01 14:10:13 | Gender |
|
5 | Update | 2013/04/01 14:11:37 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
6 | Update | 2013/11/08 10:35:05 | Key exclusion criteria |
|
7 | Update | 2013/11/08 10:42:31 | Narrative objectives1 |
|
8 | Update | 2013/11/08 10:43:42 | Interventions/Control_1 |
|
9 | Update | 2013/11/08 10:51:39 | Public title Acronym |
|
10 | Update | 2013/11/14 16:41:07 | Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
11 | Update | 2013/11/14 16:43:40 | Key inclusion criteria |
|
12 | Update | 2014/05/21 13:51:17 | Email Name of person sending information Name of person sending information Address Address |
|
13 | Update | 2015/05/29 13:33:09 | Recruitment status |
|
14 | Update | 2015/05/29 14:01:04 | Division name Division name |
|
15 | Update | 2016/05/12 10:03:16 | Name of person sending information Name of person sending information Division name Division name TEL Name of primary person or sponsor Organization |
|
16 | Update | 2018/06/14 10:41:23 | Name of person sending information Name of person sending information TEL |